Spike RBD (B.1.1.7, Alpha Variant), Avi-His-Tag (SARS-CoV-2) Recombinant

DESCRIPTION

Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.1.7, originally discovered in the United Kingdom, and contains mutation N501Y. It also contains a C-terminal Avi-Tag™ and a C-terminal His-tag. The recombinant protein is ≥90% pure following high affinity Ni-NTA purification.

DETAILS

Aa: 319-541
Mw: 28 kDa
Tags: C-terminal Avi-His-Tag
Purity: ≥90%
Genbank: MN908947
Species: SARS-CoV-2
Uniprot: P0DTD1
Mutation: Deletions: del69–70 HV, del144 Y Substitutions: N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
Shiptemp: -80°C (dry ice)
Synonyms: coronavirus, covid, covid-19, covid19, Sars-cov-2 B117, sars cov 2 Spike RBD, sarscov2, SARS-CoV-2 variant B117, Lineage B.1.1.7, Variant of Conc 20I/501Y.V1, B117 mutation, UK coronavirus, SARS-CoV-2 UK, British variant 100977-1, 100977-2
Warnings: Avoid freeze/thaw cycles.
Category: Coronavirus/Protein
Constructs: Spike RBD (B.1.1.7) (SARS-CoV-2) (319-541-Avi-His)
Description: Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.1.7, originally discovered in the United Kingdom, and contains mutation N501Y. It also contains a C-terminal Avi-Tag™ and a C-terminal His-tag. The recombinant protein is ≥90% pure following high affinity Ni-NTA purification.
Formulation: 8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol
Supplied As: Aqueous buffer solution.
Unspsc Code: 12352202
Unspsc Name: Proteins
Product Type: Protein
Biosafety Level: Not applicable (BSL-1)
Related Products: 51033, 78112, 510334, 100978
Storage Stability: At least 6 months at -80°C.
Scientific Category: Coronavirus